The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies. This year's meeting will provide the latest on regulatory, reimbursement, compliance and international trends, as well as share powerful stories of how med tech is improving patient care.
A strategic imperative for the med tech industry is accelerating product time to market which leads to increased competitive advantage, faster time to profit and reduced product development costs. However, due to global situations, translation issues can significantly impact the ability to get a product to market quickly by delaying the time it takes to receive regulatory and patent approvals.
A regulatory approval that is denied because of inaccurate translation can take up to a year before becoming eligible to reapply which delays the product getting to market and opens the door for competition.
Nancy Cardone, Business Development Manager for Across Systems will be in attendance at the MDMA Annual Conference to share valuable advice on how to minimize risk through the use of Across‘ innovative translation management software.
“Based on past conversations with customers and prospects, thinking through the translation process prior to regulatory or patent submissions saves a lot of headaches at the end of the process.“ says Cardone. “Inaccurate or low quality translations can prevent a company from gaining approval and hold up the process for up to one year giving competitors the opportunity to gain market advantage.“
Interested parties may contact Cardone to set up a time for a personal consultation and to learn more about Across System’s innovative translations solutions by emailing her at email@example.com.
For more information regarding Across visit www.across.net. For MDMA general information, schedule, and registration, please visit http://www.medicaldevices.org.